Discovery of heterocycle-containing α-naphthoflavone derivatives as water-soluble, highly potent and selective CYP1B1 inhibitors

被引:24
|
作者
Dong, Jinyun [1 ,2 ,4 ]
Huang, Guang [1 ]
Cui, Qing [1 ]
Meng, Qingqing [1 ]
Li, Shaoshun [1 ]
Cui, Jiahua [1 ,3 ]
机构
[1] Shanghai Jiao Tong Univ, Sch Pharm, 800 Dongchuan Rd, Shanghai, Peoples R China
[2] Zhejiang Chinese Med Univ, Coll Pharmaceut Sci, Hangzhou, Peoples R China
[3] Shanghai Jiao Tong Univ, Sch Environm Sci & Engn, 800 Dongchuan Rd, Shanghai, Peoples R China
[4] Chinese Acad Sci, Inst Canc & Basic Med, Hangzhou, Peoples R China
基金
中国国家自然科学基金;
关键词
CYP1; enzymes; CYP1B1; inhibitors; alpha-Naphthoflavone derivatives; SARs; DNA ADDUCT FORMATION; DESIGN; RESISTANCE; EXPRESSION; ANALOGS;
D O I
10.1016/j.ejmech.2020.112895
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cytochrome P450 1B1 (CYP1B1) has been well validated as an attractive target for cancer prevention and drug resistance reversal. In continuation of our interest in this area, herein, a set of forty-six 6,7,10-trimethoxy-alpha-naphthoflavone derivatives varying in B ring was synthesized and screened against CYP1 enzymes, leading to the identification of fluorine-containing compound 15i as the most potent and selective CYP1B1 inhibitor (IC50 value of 0.07 nM), being 84-fold more potent than that of the template molecule ANF. Alternatively, the amino-substituted derivative 13h not only possessed a potent inhibitory effect on CYP1B1 (IC50 value of 0.98 nM), but also had a substantially increased water solubility as compared with the lead ANF (311 mu g/mL for 13h and <5 mu g/mL for ANF). The current study expanded the structural diversity of CYP1B1 inhibitors, and compound 13h could be considered as a promising starting point with great potential for further studies. (c) 2020 Elsevier Masson SAS. All rights reserved.
引用
收藏
页数:12
相关论文
共 50 条
  • [41] Identification of Imidazo[1,2-b]pyridazine Derivatives as Potent, Selective, and Orally Active Tyk2 JH2 Inhibitors
    Liu, Chunjian
    Lin, James
    Moslin, Ryan
    Tokarski, John S.
    Muckelbauer, Jodi
    Chang, ChiehYing
    Tredup, Jeffrey
    Xie, Dianlin
    Park, Hyunsoo
    Li, Peng
    Wu, Dauh-Rurng
    Strnad, Joann
    Zupa-Fernandez, Adriana
    Cheng, Lihong
    Chaudhry, Charu
    Chen, Jing
    Chen, Cliff
    Sun, Huadong
    Elzinga, Paul
    D'arienzo, Celia
    Gillooly, Kathleen
    Taylor, Tracy L.
    McIntyre, Kim W.
    Salter-Cid, Luisa
    Lombardo, Louis J.
    Carter, Percy H.
    Aranibar, Nelly
    Burke, James R.
    Weinstein, David S.
    ACS MEDICINAL CHEMISTRY LETTERS, 2019, 10 (03): : 383 - 388
  • [42] Discovery of potent and selective inhibitors of human aminopeptidases ERAP1 and ERAP2 by screening libraries of phosphorus-containing amino acid and dipeptide analogues
    Weglarz-Tomczak, Ewelina
    Vassiliou, Stamatia
    Mucha, Artur
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2016, 26 (16) : 4122 - 4126
  • [43] Discovery of 6-Phenylpyrimido[4,5-b][1,4]oxazines as Potent and Selective Acyl CoA:Diacylglycerol Acyltransferase 1 (DGAT1) Inhibitors with in Vivo Efficacy in Rodents
    Fox, Brian M.
    Sugimoto, Kazuyuki
    Iio, Kiyosei
    Yoshida, Atsuhito
    Zhang, Jian
    Li, Kexue
    Hao, Xiaolin
    Labelle, Marc
    Smith, Marie-Louise
    Rubenstein, Steven M.
    Ye, Guosen
    McMinn, Dustin
    Jackson, Simon
    Choi, Rebekah
    Shan, Bei
    Ma, Ji
    Miao, Shichang
    Matsui, Takuya
    Ogawa, Nobuya
    Suzuki, Masahiro
    Kobayashi, Akio
    Ozeki, Hidekazu
    Okuma, Chihiro
    Ishii, Yukihito
    Tomimoto, Daisuke
    Furakawa, Noboru
    Tanaka, Masahiro
    Matsushita, Mutsuyoshi
    Takahashi, Mitsuru
    Inaba, Takashi
    Sagawa, Shoichi
    Kayser, Frank
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (08) : 3464 - 3483
  • [44] Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase
    Zhao, Fei
    Zhang, Jing
    Zhang, Leduo
    Hao, Yu
    Shi, Chen
    Xia, Guangxin
    Yu, Jianxin
    Liu, Yanjun
    BIOORGANIC & MEDICINAL CHEMISTRY, 2016, 24 (18) : 4281 - 4290
  • [45] Discovery of indazole-pyridinone derivatives as a novel class of potent and selective MNK1/2 kinase inhibitors that protecting against endotoxin-induced septic shock
    Dreas, Agnieszka
    Kucwaj-Brysz, Katarzyna
    Pyziak, Karolina
    Kulesza, Urszula
    Wincza, Ewelina
    Fabritius, Charles-Henry
    Michalik, Kinga
    Gabor-Worwa, Ewelina
    Golas, Aniela
    Milik, Mariusz
    Masiejczyk, Magdalena
    Majewska, Eliza
    Pysniak, Kazimiera
    Wojcik-Trechcinska, Urszula
    Sandowska-Markiewicz, Zuzanna
    Brzozka, Krzysztof
    Ostrowski, Jerzy
    Rzymski, Tomasz
    Mikula, Michal
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 213
  • [46] Discovery and biological evaluation of some (1H-1,2,3-triazol-4-yl) methoxybenzaldehyde derivatives containing an anthraquinone moiety as potent xanthine oxidase inhibitors
    Zhang, Ting-jian
    Li, Song-ye
    Yuan, Wei-yan
    Wu, Qing-xia
    Wang, Lin
    Yang, Su
    Sun, Qi
    Meng, Fan-hao
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (04) : 729 - 732
  • [47] Discovery of bis-aryl urea derivatives as potent and selective Limk inhibitors: Exploring Limk1 activity and Limk1/ROCK2 selectivity through a combined computational study
    Cui, Jiaxin
    Ding, Mei
    Deng, Wei
    Yin, Yan
    Wang, Zhonghua
    Zhou, Hong
    Sun, Guofeng
    Jiang, Yu
    Feng, Yangbo
    BIOORGANIC & MEDICINAL CHEMISTRY, 2015, 23 (23) : 7464 - 7477
  • [48] Water-Soluble Cp Ruthenium Complex Containing 1,3,5-Triaza-7-phosphaadamantane and 8-Thiotheophylline Derivatives: Synthesis, Characterization, and Antiproliferative Activity
    Hajji, Lazhar
    Saraiba-Bello, Cristobal
    Romerosa, Antonio
    Segovia-Torrente, Gaspar
    Serrano-Ruiz, Manuel
    Bergamini, Paola
    Cannella, Alessandro
    INORGANIC CHEMISTRY, 2011, 50 (03) : 873 - 882
  • [49] Discovery of Potent, Selective, and Brain-Penetrant 1H-Pyrazol-5-yl-1H-pyrrolo[2,3-b]pyridines as Anaplastic Lymphoma Kinase (ALK) Inhibitors
    Fushimi, Makoto
    Fujimori, Ikuo
    Wakabayashi, Takeshi
    Hasui, Tomoaki
    Kawakita, Youichi
    Imamura, Keisuke
    Kato, Tomoko
    Murakami, Morio
    Ishii, Tsuyoshi
    Kikko, Yorifumi
    Kasahara, Maki
    Nakatani, Atsushi
    Hiura, Yuto
    Miyamoto, Maki
    Saikatendu, Kumar
    Zou, Hua
    Lane, Scott Weston
    Lawson, J. David
    Imoto, Hiroshi
    JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (10) : 4915 - 4935
  • [50] Probing Substituents in the 1-and 3-Position: Tetrahydropyrazino-Annelated Water-Soluble Xanthine Derivatives as Multi-Target Drugs With Potent Adenosine Receptor Antagonistic Activity
    Koch, Pierre
    Brunschweiger, Andreas
    Namasivayam, Vigneshwaran
    Ullrich, Stefan
    Maruca, Annalisa
    Lazzaretto, Beatrice
    Kueppers, Petra
    Hinz, Sonja
    Hockemeyer, Joerg
    Wiese, Michael
    Heer, Jag
    Alcaro, Stefano
    Kiec-Kononowicz, Katarzyna
    Mueler, Christa E.
    FRONTIERS IN CHEMISTRY, 2018, 6